Summarized by Masters of Longevity from Longevity Docs News.
Kentucky blocked compounding and shipping of six HHS-listed peptides for patients.

Key Takeaways
- Kentucky pharmacists were ordered to stop compounding the six peptides.
- The federal HHS nonenforcement policy was not found to preempt state law.
- Clinical efficacy in humans for these peptides remains limited and unproven.



